Sobi to present new data at ISTH 2022
STOCKHOLM, June 24, 2022 /PRNewswire/ -- Sobi® will present new data at ISTH 2022, the 30th Congress of the...
Source: europapress.es
Page 8 - Anders Ullman News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Anders Ullman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Anders Ullman Today - Breaking & Trending Today
Swedish Orphan Biovitrum AB: New data reinforce robust efficacy and safety profile of Aspaveli/Empaveli (pegcetacoplan) for PNH at the EHA2022 Congress
STOCKHOLM, June 10, 2022 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi) (STO:SOBI) and Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today reported new analyses of phase 3 studies
Source: finanznachrichten.de
New data reinforce robust efficacy and safety profile of Aspaveli/Empaveli (pegcetacoplan) for PNH at the EHA2022 Congre
STOCKHOLM, June 10, 2022 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) (STO:SOBI) and Apellis...
Source: europapress.es
Swedish Orphan Biovitrum AB: First patient dosed in the VALIANT phase 3 study of pegcetacoplan for IC-MPGN and C3G, rare kidney diseases with high unmet medical need
STOCKHOLM, June 7, 2022 /PRNewswire/ -- Sobi (STO:SOBI) and Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the first patient has been dosed in the VALIANT phase 3 study investigating
Source: finanznachrichten.de
FDA grants Breakthrough Therapy designation to haemophilia A treatment
The US FDA has granted Breakthrough Therapy designation to Swedish Orphan Biovitrum (Sobi) and Sanofi’s efanesoctocog alfa (BIVV001) to treat haemophilia A.